Imipramine inhibits soluble enkephalin-degrading aminopeptidase activity in vitro

European Journal of Pharmacology

Volumn 360, Issue 1, 1998, Pages 113-116

  Gallego, Mónica ^a   Casis, Luis ^a   Casis, Oscar ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Aminopeptidase; Enzyme inhibition; Imipramine

Indexed keywords

AMINOPEPTIDASE; IMIPRAMINE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME INHIBITION; ENZYME KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINOPEPTIDASES; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALINS; ENZYME INHIBITORS; IMIPRAMINE; KINETICS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 0032582547     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00686-4     Document Type: Article

References (15)

1. Belluzzi J.D., Stein L.L. Enkephalin may mediate euphoria and drive-reduction reward. Nature. 266:1977;556-558.
2. Bouboutou R., Waksman G., Devin J., Fournie-Zaluski M.C., Roques B.P. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes. Life Sci. 35:1984;1023-1030.
3. Chaillet P., Marçais-Collado H., Costentin J., Ching-Cheng Y., De La Baume S., Schwartz J.C. Inhibition of enkephalin metabolism by, and antinociceptive activity of bestatin, an aminopeptidase inhibitor. Eur. J. Pharmacol. 86:1983;329-336.
4. De Felipe C., De Ceballos M.L., Gil C., Fuentes J.A. Chronic antidepressant treatment increases enkephalin levels in n. acumbens and striatum of the rat. Eur. J. Pharmacol. 112:1985;119-122.
5. De Felipe C., De Ceballos M.L., Gil C., Fuentes J.A. Hypoalgesia induced by antidepressants in mice: a case for opioids and serotonin. Eur. J. Pharmacol. 125:1986;193-199.
6. De Felipe C., Jimenez I., Castro A., Fuentes J.A. Antidepressant actions of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases. Eur. J. Pharmacol. 159:1989;175-180.
7. De Gandarias J.M., Casis O., Varona A., Gallego M., Irazusta J., Casis L. Interaction mechanisms of imipramine and desipramine with enkephalin-degrading aminopeptidases in vitro. Life Sci. 61:1997;321-326.
8. Hummel T., Hummel C., Friedel Y., Pauli E., Kobal G.A. A comparison of the antinociceptive effects of imipramine tramadol and ampirtoline. Br. J. Clin. Pharmacol. 37:1994;325-333.
9. Konkoy C.S., Waters S.M., Davis T.P. Subchronic haloperidol administration decreases aminopeptidase N activity and [Met5] enkephalin metabolism in rat striatum and cortex. Eur. J. Pharmacol. 297:1996;47-51.
10. Maldonado R., Valverde O., Turcaud S., Fournie-Zaluski M.C., Roques B.P. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation. Pain. 58:1994;77-83.
11. Perrot S., Kaiser V., Fournie-Zaluski M.C., Roques B.P., Gilbaud G. Antinociceptive effects of systemic PC12, a prodrug mixed inhibitor of enkephalin-degrading enzymes. Eur. J. Pharmacol. 241:1994;129-133.
12. Shimamura M., Hazato T., Katayama T. A membrane-bound aminopeptidase isolated from monkey brain and its action on enkephalin. Biochim. Biophys. Acta. 756:1983;223-229.
13. Staunton D.A., Deyo S.N., Shoemaker D.J., Ettemberg A., Bloom F.E. Effect of chronic lithium treatment on enkephalin systems and pain responsiveness. Life Sci. 31:1982;1837-1840.
14. Tejedor-Real P., Mico J.A., Maldonado R., Roques B.P., Gibert-Rahola J. Implication of opioid system in the learned helplessness model of depression. Pharmacol. Biochem. Behav. 52:1995;145-152.
15. Van Amsterdam J.G., Van Buuren K.J., Soudijn W. Purification and characterisation of enkephalin-degrading enzymes from calf brain striatum. Biochem. Biophys. Res. Commun. 115:1983;632-641.